GS-5734
Showing 1 - 25 of 281
Ebola Trial in Forécariah, Monrovia (GS-5734, Placebo Comparator)
Completed
- Ebola
- GS-5734
- Placebo Comparator
-
Forécariah, Maferinyah, Guinea
- +1 more
Jan 25, 2022
COVID-19, Remdesivir, SARS-CoV-2 Trial in Beijing (Remdesivir, Remdesivir )
Terminated
- COVID-19
- +2 more
- Remdesivir
- Remdesivir placebo
-
Beijing, Beijing, ChinaBin Cao
Apr 13, 2020
COVID-19, SARS-CoV-2 Trial in Wuhan (Remdesivir, Remdesivir )
Suspended
- COVID-19
- SARS-CoV-2
- Remdesivir
- Remdesivir placebo
-
Wuhan, Hubei, ChinaJin Yin-tan hospital
Apr 13, 2020
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
Covid19 Trial in Dhaka (Remdesivir, Standard of Care)
Completed
- Covid19
- Remdesivir
- Standard of Care
-
Dhaka, BangladeshCombined Military Hospital
Aug 9, 2021
Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- GS-0272
- Placebo
- (no location specified)
Sep 4, 2023
Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))
Enrolling by invitation
- Alcohol Consumption
- Control
- +2 more
-
Palo Alto, CaliforniaStanford University
May 8, 2023
Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)
Not yet recruiting
- Chronic Hepatitis B
- GS-2829
- +3 more
- (no location specified)
Mar 14, 2023
Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))
Not yet recruiting
- Genetic Predisposition
- Next-Generation Sequencing (NGS)
-
Tübingen, GermanyUniversity Hospital Tübingen
Sep 22, 2023
Gastroschisis Trial in Houston (fetoscopy)
Recruiting
- Gastroschisis
- fetoscopy
-
Houston, TexasTexas Children's Hospital
Jan 20, 2023
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023